{
    "2018-06-28": [
        [
            {
                "time": "2023-10-15",
                "original_text": "Novo Nordisk Reports Headline Results From Phase 3a Trial With Oral Semaglutide",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Phase 3a Trial",
                        "Oral Semaglutide",
                        "Headline Results"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}